Jane Street’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-6,340
| Closed | -$124K | – | 6481 |
|
|
2024
Q1 | $124K | Buy |
6,340
+3,483
| +122% | +$67.9K | ﹤0.01% | 5206 |
|
|
2023
Q4 | $59.1K | Buy |
+2,857
| New | +$59.1K | ﹤0.01% | 5374 |
|
|
2023
Q3 | – | Sell |
-520
| Closed | -$17.5K | – | 5629 |
|
|
2023
Q2 | $17.5K | Sell |
520
-5,481
| -91% | -$184K | ﹤0.01% | 5074 |
|
|
2023
Q1 | $250K | Buy |
+6,001
| New | +$250K | ﹤0.01% | 4449 |
|
|
2022
Q4 | – | Sell |
-1,274
| Closed | -$63K | – | 6145 |
|
|
2022
Q3 | $63K | Buy |
1,274
+161
| +14% | +$7.96K | ﹤0.01% | 5040 |
|
|
2022
Q2 | $44K | Buy |
1,113
+738
| +197% | +$29.2K | ﹤0.01% | 4947 |
|
|
2022
Q1 | $14K | Sell |
375
-2,365
| -86% | -$88.3K | ﹤0.01% | 5421 |
|
|
2021
Q4 | $268K | Buy |
2,740
+2,338
| +582% | +$229K | ﹤0.01% | 4139 |
|
|
2021
Q3 | $50K | Sell |
402
-412
| -51% | -$51.2K | ﹤0.01% | 4885 |
|
|
2021
Q2 | $102K | Buy |
+814
| New | +$102K | ﹤0.01% | 4739 |
|
|
2021
Q1 | – | Sell |
-463
| Closed | -$42K | – | 5318 |
|
|
2020
Q4 | $42K | Sell |
463
-229
| -33% | -$20.8K | ﹤0.01% | 3750 |
|
|
2020
Q3 | $51K | Sell |
692
-4,924
| -88% | -$363K | ﹤0.01% | 3566 |
|
|
2020
Q2 | $478K | Buy |
5,616
+2,114
| +60% | +$180K | ﹤0.01% | 2577 |
|
|
2020
Q1 | $253K | Buy |
+3,502
| New | +$253K | ﹤0.01% | 2710 |
|
|
2019
Q3 | – | Sell |
-3,632
| Closed | -$195K | – | 3907 |
|
|
2019
Q2 | $195K | Buy |
+3,632
| New | +$195K | ﹤0.01% | 3139 |
|